Bausch Health Companies Inc (TSX: BHC) is a pharmaceutical and medical products company that develops, manufactures, and markets a range of branded and generic drugs along with medical devices. It generates revenue through transactional product sales across its pharmaceutical and medical device segments. The company is listed on the Toronto Stock Exchange and files annual reports with the SEC under the Securities Exchange Act of 1934. Based on the 10-K filed February 19, 2026 (accession 000088559026000023), the filing confirms BHC's status as a well-known seasoned issuer. The excerpts provided do not disclose segment revenue figures, specific brand names, customer concentration data, geographic revenue mix, named competitors, or leadership details sufficient to characterize those dimensions with source-grounded specificity.

Revenue model

Product sales of branded pharmaceuticals, generic drugs, and medical devices on a transactional basis. Specific revenue figures and segment breakdowns are not supported by the provided filing excerpts.

Products and services

Pharmaceutical and medical device products. Specific brand names, drug franchises, or device product lines are not named in the provided filing excerpts.

Customers and end markets

End markets and customer types are not described in the provided filing excerpts.

Value-chain role

Pharmaceutical and medical device manufacturer and marketer.

Geographic exposure

Listed on the Toronto Stock Exchange and files with the SEC. Specific geographic revenue breakdown is not supported by the provided filing excerpts.

Source: SEC 10-K, filed 2026-02-19

Industry: Pharmaceutical Preparations Peers: SNDL Inc